Sort
51,593 grants matching “hepatitis”
Epigallocatechin gallate for prevention of lethal cirrhosis complications
$684,526Yujin Hoshida · Ut Southwestern Medical Center · R01 · FY2023 · CA
Prolonged Daily Fasting As a Viable Alternative to Caloric Restriction in At-Risk Obese Humans
$684,484Lisa Senye Chow · University Of Minnesota · R01 · FY2021 · DK
WOMENS INTERAGENCY HIV STUDY
$684,468Suny Downstate Medical Center · U01 · FY2003 · AI
Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women
$684,441Andrea A. Kovacs · University Of Southern California · R01 · FY2020 · DA
The NRF2-FBP1 crossregulatory loop and the control of healthy and diseased liver metabolism
$684,436Michael Karin · University Of California, San Diego · R01 · FY2023 · DK
Pharmacy Referral Intervention: IDU Access to Services
$684,433Crystal M Fuller · New York Academy Of Medicine · R01 · FY2009 · DA
microRNAs in Human Cancer
$684,342Gregory J Hannon · Cold Spring Harbor Laboratory · P01 · FY2010 · CA
Validating a 3rd-generation methylation measure of accelerated aging: DunedinPoAm4x
$684,340Terrie Edith Moffitt · Duke University · R01 · FY2025 · AG
Small molecules for expansion of islet beta-cell mass in diabetes
$684,336Jonathan Zachary Sexton · University Of Michigan At Ann Arbor · R01 · FY2019 · DK
HIV, HCV and the Menopausal Transition: Effects on Steatosis and Fibrosis Progression
$684,328Phyllis C Tien · Northern California Institute/Res/Edu · R01 · FY2018 · DK
Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasis
$684,278Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
Changes in Coronary Noncalcified Volume in Relation to Changes in Cocaine Use
$684,265Shenghan Lai · Johns Hopkins University · R01 · FY2015 · DA
Obesity Brain Expression
$684,262Anita L Destefano · Boston University Medical Campus · R01 · FY2016 · DK
1/2 Alcohol Associated Comorbidities and Microbiome Evaluation in HIV (ACME HIV)
$684,228Matthew S Freiberg · Vanderbilt University Medical Center · U01 · FY2017 · AA
An HB Vaccine Model For HIV Vaccine Trials in Drug Users
$684,213University Of Texas Hlth Sci Ctr Houston · R01 · FY2003 · DA
Sickle Cell Disease and Sickle Cell Trait Protection Against HIV-1-infection in Africans and African Americans
$684,145Sergei Nekhai · Howard University · R01 · FY2023 · HL
Integrative Polygenic Genetic Studies of Non-alcoholic Fatty Liver Disease
$684,141Elizabeth K Speliotes · University Of Michigan At Ann Arbor · R01 · FY2022 · DK
Macrophage-targeting Nanoplatforms as Immunotherapy against Pulmonary Infections
$684,136Michael J Sailor · University Of California, San Diego · R01 · FY2024 · AI
Pathogenesis of youth onset pre-diabetes and Type 2 diabetes
$684,085Sonia Caprio · Yale University · R01 · FY2025 · DK
Exercise Regulation of Glucose Homeostasis
$684,014Laurie J Goodyear · Joslin Diabetes Center · R01 · FY2024 · DK
Mechanisms of SGLT2 Inhibition in Pediatric NAFLD
$683,996Justin R. Ryder · Lurie Children'S Hospital Of Chicago · R01 · FY2024 · DK
Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis
$683,885Hugo R Rosen · University Of Southern California · R01 · FY2021 · MD
Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis
$683,885Veronica Wendy Setiawan · University Of Southern California · R01 · FY2022 · MD
HCC Risk Stratification in MAFLD Cirrhosis
$683,729Hashem B El-Serag · Baylor College Of Medicine · P01 · FY2023 · CA
A novel vaccine to prevent HCV infection and hence liver cancer
$683,700Ellen S Vitetta · Ut Southwestern Medical Center · RC2 · FY2009 · CA